CLINICAL_TRIALS
trial_result
· 2014-08-29
Clinical Trial Update: A Long Term Safety Study of Suvorexant in Participants With Primary Insomnia (MK-4305-009 AM3) [Phase 3]
Summary
Phase 3 long-term safety study of suvorexant in participants with primary insomnia completed; results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Insomnia | Phase 3 | Status: COMPLETED | Results posted: 2014-08-29